26.01.2021 LANXESS Aktiengesellschaft  DE0005470405

DGAP-Adhoc: LANXESS Aktiengesellschaft: EBITDA pre exceptionals for fourth quarter 2020 estimated above market expectations


 

DGAP-Ad-hoc: LANXESS Aktiengesellschaft / Key word(s): Preliminary Results/Quarter Results
LANXESS Aktiengesellschaft: EBITDA pre exceptionals for fourth quarter 2020 estimated above market expectations

26-Jan-2021 / 13:13 CET/CEST
Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.


Ad hoc according to Art. 17 paragraph 1 MMVO

LANXESS Aktiengesellschaft: EBITDA pre exceptionals for fourth quarter 2020 estimated above market expectations


Specialty chemicals company LANXESS expects to achieve fourth quarter 2020 EBITDA pre exceptionals that considerably exceeds average market expectations and previous year's level.

EBITDA pre exceptionals for the fourth quarter 2020 is estimated to amount to EUR 200 million which exceeds average market expectations of EUR 181 million by 10 percent.

The fourth quarter result was positively influenced by a stronger than expected increase in demand especially from the automotive industry particularly in the month of December. LANXESS supplies this industry mainly through its Engineering Materials segment. The segments Advanced Intermediates and Specialty Additives also recorded a business development above expectation.

In the prior-year quarter, LANXESS EBITDA pre exceptionals reached EUR 197 million.

LANXESS will release its final results for the fourth quarter 2020 and the fiscal year 2020 on March 11, 2021. All figures provided in this release are preliminary and unaudited.

Cologne, 26 January 2021

Contact:
André Simon

LANXESS AG
Head of Investor Relations

Kennedyplatz 1
50569 Köln, Deutschland
Telefon: +49 221 8885-3494
Fax: +49 221 8885-4944
E-Mail: [email protected]

Forward-Looking Statements
This company release contains certain forward-looking statements, including assumptions, opinions, expectations and views of the company or cited from third party sources. Various known and unknown risks, uncertainties and other factors could cause the actual results, financial position, development or performance of LANXESS AG to differ materially from the estimations expressed or implied herein. LANXESS AG does not guarantee that the assumptions underlying such forward-looking statements are free from errors, nor does it accept any responsibility for the future accuracy of the opinions expressed in this presentation or the actual occurrence of the forecast developments. No representation or warranty (expressed or implied) is made as to, and no reliance should be placed on, any information, estimates, targets and opinions contained herein, and no liability whatsoever is accepted as to any errors, omissions or misstatements contained herein, and accordingly, no representative of LANXESS AG or any of its affiliated companies or any of such person's officers, directors or employees accepts any liability whatsoever arising directly or indirectly from the use of this document.

Information and Explanation of the Issuer to this News:


 

26-Jan-2021 CET/CEST The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de


Language: English
Company: LANXESS Aktiengesellschaft
Kennedyplatz 1
50569 Cologne
Germany
Phone: +49 (0)221 8885-3494
Fax: +49 (0)221 8885-4944
E-mail: [email protected]
Internet: www.lanxess.com
ISIN: DE0005470405
WKN: 547040
Indices: MDAX
Listed: Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Hanover, Munich, Stuttgart, Tradegate Exchange
EQS News ID: 1163319

 
End of Announcement DGAP News Service

1163319  26-Jan-2021 CET/CEST

fncls.ssp?fn=show_t_gif&application_id=1163319&application_name=news&site_id=boersengefluester_html


Die wichtigsten Finanzdaten auf einen Blick
  2016 2017 2018 2019 2020 2021 2022e
Umsatzerlöse1 7.699,00 6.530,00 7.197,00 6.802,00 6.104,00 7.557,00 7.660,00
EBITDA1,2 995,00 709,00 935,00 910,00 757,00 863,00 1.100,00
EBITDA-Marge3 12,92 10,86 12,99 13,38 12,40 11,42 14,36
EBIT1,4 464,00 299,00 504,00 407,00 253,00 350,00 560,00
EBIT-Marge5 6,03 4,58 7,00 5,98 4,14 4,63 7,31
Jahresüberschuss1 195,00 124,00 523,00 191,00 902,00 267,00 384,00
Netto-Marge6 2,53 1,90 7,27 2,81 14,78 3,53 5,01
Cashflow1,7 689,00 868,00 586,00 643,00 585,00 407,00 0,00
Ergebnis je Aktie8 2,10 0,95 4,71 2,32 10,22 3,09 2,55
Dividende8 0,70 0,80 0,90 0,95 1,00 1,05 0,70
Quelle: boersengefluester.de und Firmenangaben

  Geschäftsbericht 2021 - Kostenfrei herunterladen.  
1 in Mio. Euro; 2 EBITDA = Ergebnis vor Zinsen, Steuern und Abschreibungen; 3 EBITDA in Relation zum Umsatz; 4 EBIT = Ergebnis vor Zinsen und Steuern; 5 EBIT in Relation zum Umsatz; 6 Jahresüberschuss (-fehlbetrag) in Relation zum Umsatz; 7 Cashflow aus der gewöhnlichen Geschäftstätigkeit; 8 in Euro; Quelle: boersengefluester.de

Wirtschaftsprüfer: PricewaterhouseCoopers

INVESTOR-INFORMATIONEN
©boersengefluester.de
Lanxess
WKN Kurs in € Einschätzung Börsenwert in Mio. €
547040 36,000 Halten 3.108,47
KGV 2023e KGV 10Y-Ø BGFL-Ratio Shiller-KGV
12,41 17,95 0,71 12,74
KBV KCV KUV EV/EBITDA
0,85 7,64 0,41 6,65
Dividende '22 in € Dividende '23e in € Div.-Rendite '23e
in %
Hauptversammlung
0,70 0,70 1,94 24.05.2023
Q1-Zahlen Q2-Zahlen Q3-Zahlen Bilanz-PK
10.05.2023 04.08.2023 09.11.2022 15.03.2023
Abstand 60Tage-Linie Abstand 200Tage-Linie Performance YtD Performance 52 Wochen
2,99% -1,42% -33,95% -31,82%
    
Weitere Ad-hoc und Unternehmensrelevante Mitteilungen zu LANXESS Aktiengesellschaft  ISIN: DE0005470405 können Sie bei EQS abrufen


Chemie , 547040 , LXS , XETR:LXS